| 1. |
|
|
| 2. |
- Tabiri, S, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 3. |
- Bravo, L, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 4. |
|
|
| 5. |
- Li, N., et al.
(författare)
-
Tailoring Ordered Mesoporous Titania Films via Introducing Germanium Nanocrystals for Enhanced Electron Transfer Photoanodes for Photovoltaic Applications
- 2021
-
Ingår i: Advanced Functional Materials. - : Wiley. - 1616-301X .- 1616-3028. ; 31:34
-
Tidskriftsartikel (refereegranskat)abstract
- Based on a diblock-copolymer templated sol–gel synthesis, germanium nanocrystals (GeNCs) are introduced to tailor mesoporous titania (TiO2) films for obtaining more efficient anodes for photovoltaic applications. After thermal annealing in air, the hybrid films with different GeNC content are investigated and compared with films undergoing an argon atmosphere annealing. The surface and inner morphologies of the TiO2/GeOx nanocomposite films are probed via scanning electron microscopy and grazing-incidence small-angle X-ray scattering. The crystal phase, chemical composition, and optical properties of the nanocomposite films are examined with transmission electron microscopy, X-ray photoelectron spectroscopy, and ultraviolet–visible spectroscopy. Special focus is set on the air-annealed nanocomposite films since they hold greater promise for photovoltaics. Specifically, the charge–carrier dynamics of these air-annealed nanocomposite films are studied, and it is found that, compared with pristine TiO2 photoanodes, the GeNC addition enhances the electron transfer, yielding an increase in the short-circuit photocurrent density of exemplary perovskite solar cells and thus, an enhanced device efficiency as well as a significantly reduced hysteresis.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Toma, M, et al.
(författare)
-
Left Heart Disease Phenotype in Elderly Patients with Pulmonary Arterial Hypertension: Insights from the Italian PATRIARCA Registry
- 2022
-
Ingår i: Journal of clinical medicine. - : MDPI AG. - 2077-0383. ; 11:23
-
Tidskriftsartikel (refereegranskat)abstract
- Pulmonary arterial hypertension (PAH) in the elderly is often associated with left heart disease (LHD), prompting concerns about the use of pulmonary vasodilators. The PATRIARCA registry enrolled ≥70 year-old PAH or chronic thromboembolic pulmonary hypertension (CTEPH) patients at 11 Italian centers from 1 December 2019 through 15 September 2022. After excluding those with CTEPH, post-capillary PH at the diagnostic right heart catheterization (RHC), and/or incomplete data, 23 (33%) of a total of 69 subjects met the criteria proposed in the AMBITION trial to suspect LHD. Diabetes [9 (39%) vs. 6 (13%), p = 0.01] and chronic kidney disease [14 (61%) vs. 12 (26%), p = 0.003] were more common, and the last RHC pulmonary artery wedge pressure [14 ± 5 vs. 10 ± 3 mmHg, p < 0.001] was higher and pulmonary vascular resistance [5.56 ± 3.31 vs. 8.30 ± 4.80, p = 0.02] was lower in LHD than non-LHD patients. However, PAH therapy was similar, with 13 (57%) and 23 (50%) subjects, respectively, taking two oral drugs. PAH medication patterns remained comparable between LHD and non-LHD patients also when the former [37, 54%] were identified by atrial fibrillation and echocardiographic features of LHD, in addition to the AMBITION criteria. In this real-world snapshot, elderly PAH patients were treated with pulmonary vasodilators, including combinations, despite a remarkable prevalence of a LHD phenotype.
|
|
